Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Reliability analysis of exonic-breakpoint fusions identified by DNA sequencing for predicting the efficacy of targeted therapy in non-small cell lung cancer

Fig. 1

Distribution and characteristics of exonic-breakpoint fusions identified by DNA NGS in NSCLCs. A Distribution of kinase fusions identified by DNA NGS in NSCLCs. B Distribution of intronic-, intergenic-, exonic-, and mixed-breakpoint fusions in fusion-positive NSCLCs. C Classification of exonic-breakpoint fusions. D Flowchart showing molecular analyses of exonic-breakpoint fusions in our cohort

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us